2
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other
1
Genitourinary
1
Conditions
Alcohol Drinking
11
Pancreatic Neoplasms
7
Neoplasms
5
Smoking Cessation
4
Pancreatic Cyst
4
Cancer Pain
4
Agnosia
4
Smoking
3
Pain
3
Depression
3
Prostatic Neoplasms
2
Postoperative Complications
2
Neoplasms, Cystic, Mucinous, and Serous
2
Multiple Endocrine Neoplasia Type 1
2
Lymphoma, Follicular
2
Lymphoma
2
Leukemia
2
Infections
2
Head and Neck Neoplasms
2
Gliosarcoma
2
Glioblastoma
2
Condylomata Acuminata
2
Colorectal Neoplasms
2
Central Nervous System Neoplasms
2
Cardiovascular Diseases
2
Breast Neoplasms
2
Brain Neoplasms
2
Alcoholism
2
Wounds and Injuries
1
Warts
1
Interventions
pertuzumab
1
pazopanib
1
enzalutamide
1
delta 24-sterol reductase
1
decitabine and cedazuridine drug combination
1
daratumumab
1
apalutamide
1
Validation Studies as Topic
1
Trastuzumab
1
Tape Recording
1
Surgical Procedures, Operative
1
Sunitinib
1
Sorafenib
1
Risk Assessment
1
Radiotherapy
1
Preoperative Exercise
1
Pilot Projects
1
Opdualag
1
Nutritional Support
1
Nivolumab
1
Injections, Subcutaneous
1
Focus Groups
1
Exercise
1
Ethanol
1
Bandages, Hydrocolloid
1
Ado-Trastuzumab Emtansine
1
Adiposity
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Patient Preference
×
Ethanol
×
Clear all
NCT04088968
2024-03-22
STRONG-CS
Bispebjerg Hospital
Phase NA
Unknown
100 enrolled